July 26 (Reuters) - Loblaw Companies Ltd L.TO
* Q2 revenue C$11.08 billion versus I/B/E/S view C$11.05 billion
* Q2 earnings per share C$0.89
* Loblaw Companies Ltd - qtrly drug retail (Shoppers Drug Mart) same-store sales growth was 3.7 percent
* Q2 earnings per share C$0.89
* Q2 adjusted earnings per share C$1.11
* Loblaw Companies Ltd - qtrly food retail (Loblaw) same-store sales growth was 1.0 percent, excluding gas bar
* Loblaw Companies Ltd - qtrly retail segment sales were $10,827 million, an increase of $333 million, or 3.2 percent, compared to Q2 of 2016
* Q2 earnings per share view C$1.10 -- Thomson Reuters I/B/E/S
* Loblaw Companies Ltd - Loblaw's outlook for 2017 remains unchanged
* FY2017 earnings per share view C$4.44, revenue view C$46.99 billion -- Thomson Reuters I/B/E/S
* Loblaw Companies Ltd - expected incremental impact of minimum wage increases on labour expenses is approximately $190 million in 2018
* Loblaw Companies Ltd - recently announced healthcare reform in Quebec will result in a more significant incremental impact in 2018 than in prior years